Annual Total Long Term Liabilities
$12.47 M
-$2.01 M-13.86%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual total long term liabilities is $12.47 million, with the most recent change of -$2.01 million (-13.86%) on December 31, 2022.
- During the last 3 years, AMAM annual total long term liabilities has risen by +$1.67 million (+15.46%).
Performance
AMAM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$10.83 M
-$555.00 K-4.87%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly total long term liabilities is $10.83 million, with the most recent change of -$555.00 thousand (-4.87%) on September 1, 2023.
Performance
AMAM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AMAM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.9% | - |
| 3 y3 years | +15.5% | -95.8% |
| 5 y5 years | +15.5% | - |
AMAM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.9% | at low | -25.2% | at low |
| 5 y | 5-year | -95.2% | -13.4% | -95.8% | -68.2% |
| alltime | all time | -95.2% | -13.4% | -95.8% | -68.2% |
Ambrx Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $10.83 M(-4.9%) |
| Jun 2023 | - | $11.38 M(-4.6%) |
| Mar 2023 | - | $11.93 M(-4.3%) |
| Dec 2022 | $12.47 M(-13.9%) | $12.47 M(-5.8%) |
| Jun 2022 | - | $13.24 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $14.47 M(-94.4%) | - |
| Dec 2021 | - | $14.47 M(+320.2%) |
| Jun 2021 | - | $3.44 M(-98.7%) |
| Dec 2020 | $258.91 M(+2297.7%) | - |
| Dec 2020 | - | $258.91 M |
| Dec 2019 | $10.80 M | - |
FAQ
- What is Ambrx Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Ambrx Biopharma?
- What is Ambrx Biopharma annual total long term liabilities year-on-year change?
- What is Ambrx Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ambrx Biopharma?
What is Ambrx Biopharma annual total long term liabilities?
The current annual total long term liabilities of AMAM is $12.47 M
What is the all time high annual total long term liabilities for Ambrx Biopharma?
Ambrx Biopharma all-time high annual total long term liabilities is $258.91 M
What is Ambrx Biopharma annual total long term liabilities year-on-year change?
Over the past year, AMAM annual total long term liabilities has changed by -$2.01 M (-13.86%)
What is Ambrx Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of AMAM is $10.83 M
What is the all time high quarterly long term liabilities for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly total long term liabilities is $258.91 M